tiprankstipranks
Sanofi (DE:SNW)
XETRA:SNW
Germany Market

Sanofi (SNW) Stock Forecast & Price Target

31 Followers
See the Price Targets and Ratings of:

SNW Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
4 Buy
7 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Sanofi
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SNW Stock 12 Month Forecast

Average Price Target

€93.34
▲(13.09% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is €93.34 with a high forecast of €109.75 and a low forecast of €79.82. The average price target represents a 13.09% change from the last price of €82.53.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"78":"€78","86":"€86","94":"€94","102":"€102","110":"€110"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":109.7539176615519,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€109.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93.3355718055,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€93.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":79.8210310265832,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€79.82</span>\n  </div></div>","useHTML":true}}],"tickPositions":[78,86,94,102,110],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.84,84.91030135858092,86.98060271716183,89.05090407574275,91.12120543432366,93.19150679290458,95.2618081514855,97.3321095100664,99.40241086864732,101.47271222722824,103.54301358580915,105.61331494439007,107.68361630297099,{"y":109.7539176615519,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.84,83.64735167734615,84.45470335469231,85.26205503203846,86.06940670938462,86.87675838673077,87.68411006407692,88.49146174142308,89.29881341876923,90.10616509611538,90.91351677346154,91.72086845080769,92.52822012815385,{"y":93.3355718055,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.84,82.60777161742948,82.37554323485895,82.14331485228843,81.91108646971792,81.67885808714739,81.44662970457686,81.21440132200634,80.98217293943581,80.74994455686529,80.51771617429478,80.28548779172425,80.05325940915372,{"y":79.8210310265832,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":98.013,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.037,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.91,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.08,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.99,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.71,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.94,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.71,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.04,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.72,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.84,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€109.75Average Price Target€93.34Lowest Price Target€79.82
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on DE:SNW
J.P. Morgan
J.P. Morgan
€95
Hold
15.11%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Enlivex (NASDAQ: ENLV) and Sanofi (Other OTC: SNYNF)
Kepler Capital  Analyst forecast on DE:SNW
Kepler Capital
Kepler Capital
€85
Hold
2.99%
Upside
Reiterated
03/30/26
Sanofi (SNYNF) Gets a Hold from Kepler Capital
UBS
€88
Hold
6.63%
Upside
Reiterated
03/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (NASDAQ: INCY), Sanofi (Other OTC: SNYNF) and Johnson & Johnson (NYSE: JNJ)
Deutsche Bank  Analyst forecast on DE:SNW
Deutsche Bank
Deutsche Bank
€100
Buy
21.17%
Upside
Reiterated
03/26/26
Deutsche Bank Remains a Buy on Sanofi (SNYNF)
Jefferies
€100
Buy
21.17%
Upside
Reiterated
03/26/26
Jefferies Keeps Their Buy Rating on Sanofi (SNYNF)
Bank of America Securities Analyst forecast on DE:SNW
Bank of America Securities
Bank of America Securities
€102€92
Hold
11.47%
Upside
Reiterated
03/25/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and LENZ Therapeutics (NASDAQ: LENZ)
Barclays
€85
Hold
2.99%
Upside
Reiterated
03/25/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pelthos Therapeutics (NYSE MKT: PTHS) and Sanofi (Other OTC: SNYNF)
Berenberg Bank Analyst forecast on DE:SNW
Berenberg Bank
Berenberg Bank
€105
Buy
27.23%
Upside
Reiterated
03/20/26
Sanofi (SNYNF) Gets a Buy from Berenberg Bank
Bernstein Analyst forecast on DE:SNW
Bernstein
Bernstein
€110
Buy
33.28%
Upside
Initiated
03/18/26
Analysts Are Bullish on These Healthcare Stocks: Medline (MDLN), Protagonist Therapeutics (PTGX)
Citi
€85€80
Hold
-3.07%
Downside
Reiterated
02/20/26
Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi
Goldman Sachs Analyst forecast on DE:SNW
Goldman Sachs
Goldman Sachs
€90€89
Hold
7.84%
Upside
Reiterated
01/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN), Resmed (NYSE: RMD) and Sanofi (Other OTC: SNYNF)
Leerink Partners Analyst forecast on DE:SNW
Leerink Partners
Leerink Partners
Buy
Reiterated
12/24/25
Analysts' Top Healthcare Picks: Sanofi (SNYNF), Genmab (GMAB)
HSBC
€102€100
Buy
21.17%
Upside
Reiterated
12/10/25
Sanofi price target lowered to EUR 100 from EUR 102 at HSBCSanofi price target lowered to EUR 100 from EUR 102 at HSBC
DZ BANK AG Analyst forecast on DE:SNW
DZ BANK AG
DZ BANK AG
Buy
Reiterated
10/24/25
DZ BANK AG Sticks to Its Buy Rating for Sanofi (SNYNF)
Guggenheim
€104€101
Buy
22.38%
Upside
Reiterated
10/08/25
Sanofi price target lowered to EUR 101 from EUR 104 at GuggenheimSanofi price target lowered to EUR 101 from EUR 104 at Guggenheim
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on DE:SNW
J.P. Morgan
J.P. Morgan
€95
Hold
15.11%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Enlivex (NASDAQ: ENLV) and Sanofi (Other OTC: SNYNF)
Kepler Capital  Analyst forecast on DE:SNW
Kepler Capital
Kepler Capital
€85
Hold
2.99%
Upside
Reiterated
03/30/26
Sanofi (SNYNF) Gets a Hold from Kepler Capital
UBS
€88
Hold
6.63%
Upside
Reiterated
03/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (NASDAQ: INCY), Sanofi (Other OTC: SNYNF) and Johnson & Johnson (NYSE: JNJ)
Deutsche Bank  Analyst forecast on DE:SNW
Deutsche Bank
Deutsche Bank
€100
Buy
21.17%
Upside
Reiterated
03/26/26
Deutsche Bank Remains a Buy on Sanofi (SNYNF)
Jefferies
€100
Buy
21.17%
Upside
Reiterated
03/26/26
Jefferies Keeps Their Buy Rating on Sanofi (SNYNF)
Bank of America Securities Analyst forecast on DE:SNW
Bank of America Securities
Bank of America Securities
€102€92
Hold
11.47%
Upside
Reiterated
03/25/26
Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and LENZ Therapeutics (NASDAQ: LENZ)
Barclays
€85
Hold
2.99%
Upside
Reiterated
03/25/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pelthos Therapeutics (NYSE MKT: PTHS) and Sanofi (Other OTC: SNYNF)
Berenberg Bank Analyst forecast on DE:SNW
Berenberg Bank
Berenberg Bank
€105
Buy
27.23%
Upside
Reiterated
03/20/26
Sanofi (SNYNF) Gets a Buy from Berenberg Bank
Bernstein Analyst forecast on DE:SNW
Bernstein
Bernstein
€110
Buy
33.28%
Upside
Initiated
03/18/26
Analysts Are Bullish on These Healthcare Stocks: Medline (MDLN), Protagonist Therapeutics (PTGX)
Citi
€85€80
Hold
-3.07%
Downside
Reiterated
02/20/26
Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi
Goldman Sachs Analyst forecast on DE:SNW
Goldman Sachs
Goldman Sachs
€90€89
Hold
7.84%
Upside
Reiterated
01/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (NASDAQ: REGN), Resmed (NYSE: RMD) and Sanofi (Other OTC: SNYNF)
Leerink Partners Analyst forecast on DE:SNW
Leerink Partners
Leerink Partners
Buy
Reiterated
12/24/25
Analysts' Top Healthcare Picks: Sanofi (SNYNF), Genmab (GMAB)
HSBC
€102€100
Buy
21.17%
Upside
Reiterated
12/10/25
Sanofi price target lowered to EUR 100 from EUR 102 at HSBCSanofi price target lowered to EUR 100 from EUR 102 at HSBC
DZ BANK AG Analyst forecast on DE:SNW
DZ BANK AG
DZ BANK AG
Buy
Reiterated
10/24/25
DZ BANK AG Sticks to Its Buy Rating for Sanofi (SNYNF)
Guggenheim
€104€101
Buy
22.38%
Upside
Reiterated
10/08/25
Sanofi price target lowered to EUR 101 from EUR 104 at GuggenheimSanofi price target lowered to EUR 101 from EUR 104 at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sanofi

3 Months
xxx
Success Rate
19/35 ratings generated profit
54%
Average Return
-0.30%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.29% of your transactions generating a profit, with an average return of -0.30% per trade.
1 Year
David RisingerLeerink Partners
Success Rate
19/35 ratings generated profit
54%
Average Return
+1.22%
Copying David Risinger's trades and holding each position for 1 Year would result in 54.29% of your transactions generating a profit, with an average return of +1.22% per trade.
2 Years
xxx
Success Rate
23/51 ratings generated profit
45%
Average Return
-1.69%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 45.10% of your transactions generating a profit, with an average return of -1.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SNW Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
35
25
21
13
4
Hold
7
19
25
26
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
42
44
46
39
17
In the current month, SNW has received 4 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. SNW average Analyst price target in the past 3 months is 93.34.
Each month's total comprises the sum of three months' worth of ratings.

SNW Financial Forecast

SNW Earnings Forecast

Next quarter’s earnings estimate for SNW is €1.79 with a range of €1.59 to €1.87. The previous quarter’s EPS was €1.53. SNW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SNW has Performed in-line its overall industry.
Next quarter’s earnings estimate for SNW is €1.79 with a range of €1.59 to €1.87. The previous quarter’s EPS was €1.53. SNW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year SNW has Performed in-line its overall industry.

SNW Sales Forecast

Next quarter’s sales forecast for SNW is €10.66B with a range of €10.09B to €11.13B. The previous quarter’s sales results were €23.74B. SNW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SNW has Performed in-line its overall industry.
Next quarter’s sales forecast for SNW is €10.66B with a range of €10.09B to €11.13B. The previous quarter’s sales results were €23.74B. SNW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year SNW has Performed in-line its overall industry.

SNW Stock Forecast FAQ

What is DE:SNW’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is 93.34.
    What is DE:SNW’s upside potential, based on the analysts’ average price target?
    Sanofi has 13.09% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sanofi a Buy, Sell or Hold?
          Sanofi has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Sanofi’s share price target?
            The average share price target for Sanofi is 93.34. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €109.75 ,and the lowest forecast is €79.82. The average share price target represents 13.09% Increase from the current price of €82.53.
              What do analysts say about Sanofi?
              Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Sanofi?
                To buy shares of DE:SNW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.